[go: up one dir, main page]

PA8798101A1 - Nuevas composiciones a base de taxoides - Google Patents

Nuevas composiciones a base de taxoides

Info

Publication number
PA8798101A1
PA8798101A1 PA20088798101A PA8798101A PA8798101A1 PA 8798101 A1 PA8798101 A1 PA 8798101A1 PA 20088798101 A PA20088798101 A PA 20088798101A PA 8798101 A PA8798101 A PA 8798101A PA 8798101 A1 PA8798101 A1 PA 8798101A1
Authority
PA
Panama
Prior art keywords
based compositions
new taxoid
new
taxoid
formulations
Prior art date
Application number
PA20088798101A
Other languages
English (en)
Inventor
Patricia Rortais
Carine Gachon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PA8798101A1 publication Critical patent/PA8798101A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)

Abstract

LA PRESENTE INVENCIÒN SE REFIERE A NUEVAS COMPOSICIONES A BASE DE TAXOIDES CONSTITUIDAS POR FORMULACIONES INYECTABLES DE ESTOS DERIVADOS EN FORMA DE EMULSIÒN. ESTAS FORMULACIONES SE DESTINAN A SER INYECTADAS DIRECTAMENTE POR VIA INTRAVENOSA.
PA20088798101A 2007-10-10 2008-10-08 Nuevas composiciones a base de taxoides PA8798101A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0707092A FR2922107B1 (fr) 2007-10-10 2007-10-10 Nouvelles compositions a base de taxoides

Publications (1)

Publication Number Publication Date
PA8798101A1 true PA8798101A1 (es) 2009-07-23

Family

ID=39356621

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088798101A PA8798101A1 (es) 2007-10-10 2008-10-08 Nuevas composiciones a base de taxoides

Country Status (38)

Country Link
US (1) US8481589B2 (es)
EP (1) EP2197492B1 (es)
JP (1) JP5574965B2 (es)
KR (1) KR20100075490A (es)
CN (1) CN101820918A (es)
AR (1) AR072333A1 (es)
AT (1) ATE534406T1 (es)
AU (1) AU2008345527A1 (es)
BR (1) BRPI0818597A2 (es)
CA (1) CA2701789A1 (es)
CL (1) CL2008003002A1 (es)
CO (1) CO6260107A2 (es)
CR (1) CR11335A (es)
CY (1) CY1112388T1 (es)
DK (1) DK2197492T3 (es)
DO (1) DOP2010000098A (es)
EA (1) EA016619B1 (es)
ES (1) ES2377352T3 (es)
FR (1) FR2922107B1 (es)
GT (1) GT201000075A (es)
HR (1) HRP20120165T1 (es)
IL (1) IL204950A0 (es)
MA (1) MA31840B1 (es)
MX (1) MX2010003914A (es)
NI (1) NI201000048A (es)
NZ (1) NZ584544A (es)
PA (1) PA8798101A1 (es)
PE (1) PE20090962A1 (es)
PL (1) PL2197492T3 (es)
PT (1) PT2197492E (es)
RS (1) RS52131B (es)
SI (1) SI2197492T1 (es)
TN (1) TN2010000129A1 (es)
TW (1) TW200922552A (es)
UA (1) UA97418C2 (es)
UY (1) UY31386A1 (es)
WO (1) WO2009083664A1 (es)
ZA (1) ZA201002504B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120065255A1 (en) * 2009-10-19 2012-03-15 Nagesh Palepu Cabazitaxel formulations and methods of preparing thereof
JP5566466B2 (ja) 2009-10-29 2014-08-06 アバンテイス・フアルマ・エス・アー カバジタキセルの新規の抗腫瘍的使用
SG10201503234SA (en) 2010-05-03 2015-06-29 Teikoku Pharma Usa Inc Non-Aqueous Taxane Pro-Emulsion Formulations and Methods of Making and Using the Same
JP2012051823A (ja) * 2010-08-31 2012-03-15 Fujifilm Corp 難容性薬物含有水中油型乳化組成物及びその製造方法
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN104225615B (zh) * 2014-09-24 2017-02-01 东南大学 一种紫杉醇类磷脂化合物、其药物组合物及应用
EP3384961B1 (en) * 2017-04-05 2021-10-13 RaySearch Laboratories AB System and method for modelling of dose calculation in radiotherapy treatment planning

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
US5750561A (en) * 1991-07-08 1998-05-12 Rhone-Poulenc Rorer, S.A. Compositions containing taxane derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
FR2698543B1 (fr) 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
US6537579B1 (en) * 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US6372780B2 (en) * 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
CA2341191A1 (en) * 1998-08-20 2000-03-02 Aventis Pharma S.A. New use of taxoid derivatives
US20020001613A1 (en) * 2000-02-08 2002-01-03 Susan Niemiec Method of manufacturing liposomes
US20030099674A1 (en) * 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
KR20060015553A (ko) * 2003-04-29 2006-02-17 백스터 인터내셔널 인코포레이티드 항균제에 대해 내성이 있는 것으로 통상 간주되는 유기체에대하여 효능있는 항균제가 되도록 하기 위한 제형
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
EP1498120A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid formulations for the oral administration of taxoids
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
JP5089887B2 (ja) * 2006-01-23 2012-12-05 日本精化株式会社 生理活性物質含有複合体

Also Published As

Publication number Publication date
MX2010003914A (es) 2010-05-17
FR2922107A1 (fr) 2009-04-17
PT2197492E (pt) 2012-02-20
CN101820918A (zh) 2010-09-01
PL2197492T3 (pl) 2012-05-31
DK2197492T3 (da) 2012-03-12
BRPI0818597A2 (pt) 2015-04-22
MA31840B1 (fr) 2010-11-01
KR20100075490A (ko) 2010-07-02
JP2011500542A (ja) 2011-01-06
UA97418C2 (ru) 2012-02-10
TW200922552A (en) 2009-06-01
CA2701789A1 (fr) 2009-07-09
CO6260107A2 (es) 2011-03-22
IL204950A0 (en) 2010-11-30
CY1112388T1 (el) 2015-12-09
SI2197492T1 (sl) 2012-03-30
JP5574965B2 (ja) 2014-08-20
FR2922107B1 (fr) 2010-02-26
HRP20120165T1 (hr) 2012-03-31
WO2009083664A1 (fr) 2009-07-09
UY31386A1 (es) 2009-05-29
EA201070448A1 (ru) 2010-08-30
EP2197492A1 (fr) 2010-06-23
AU2008345527A1 (en) 2009-07-09
ZA201002504B (en) 2011-06-29
EP2197492B1 (fr) 2011-11-23
WO2009083664A8 (fr) 2010-05-14
US20100311825A1 (en) 2010-12-09
ATE534406T1 (de) 2011-12-15
CL2008003002A1 (es) 2009-10-16
DOP2010000098A (es) 2010-04-30
GT201000075A (es) 2012-04-11
RS52131B (sr) 2012-08-31
CR11335A (es) 2010-08-13
EA016619B1 (ru) 2012-06-29
TN2010000129A1 (fr) 2011-09-26
PE20090962A1 (es) 2009-08-10
US8481589B2 (en) 2013-07-09
AR072333A1 (es) 2010-08-25
NI201000048A (es) 2010-08-20
ES2377352T3 (es) 2012-03-26
NZ584544A (en) 2012-04-27

Similar Documents

Publication Publication Date Title
PA8798101A1 (es) Nuevas composiciones a base de taxoides
BR112013007362A2 (pt) composição farmacêutica
PA8809001A1 (es) Compuestos organicos
CR10405A (es) Formulaciones novedosas que establizan e inhiben la precipitacion de composiciones inmunogenicas
CR11454A (es) Derivados de isoxazolo-piridina
GT200700060A (es) Compuestos de benzimidazolilo
BRPI0914375A2 (pt) ''composições antiperspirantes''
BRPI0923731A2 (pt) "formulações injetáveis de toxinas botulínicas".
DOP2011000009A (es) Amidofenoxiindazoles utiles como inhibidores de c-met
EA201270308A1 (ru) Конъюгаты димеров пирроло [1,4]бензодиазепина в качестве противоракового средства
EP2421528A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING 1,3,4-OXADIAZOLE DERIVATIVES
BR112012030699A2 (pt) métodos para tratar câncer de bexiga
MA32369B1 (fr) Composes de benzene sulfonamide thiazole et oxazole
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
MA32979B1 (fr) Derives aminoesterifies d'alcaloides et composition medicinale les incluant
PA8855001A1 (es) Monocarbamas
BR112012030482A2 (pt) tratamento de diabetes tipo 2
DOP2010000329A (es) Inhibidores de la renina
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
PA8772401A1 (es) Macrólidos
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
CR11449A (es) Productos intermedios gsm
IL211050A0 (en) Injectable taxane pharmaceutical composition
UY32360A (es) Compuestos de etanamina y métodos de utilización de los mismos 545